scorecardresearch
Friday, Sep 30, 2022

EU regulator authorises Pfizer’s Covid vaccine for kids 5-11

🔴 It is the first time the European Medicines Agency has cleared a Covid-19 vaccine for use in young children.

children covid shotA child gets a shot of the Pfizer vaccine for COVID-19 from a nurse at the National College school in Asuncion, Paraguay Nov. 22, 2021. (AP)

The European Union’s drug regulator on Thursday authorised Pfizer’s coronavirus vaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent.

It is the first time the European Medicines Agency has cleared a COVID-19 vaccine for use in young children.

The agency said it “recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.”

At least one country facing spiking infections didn’t wait for the EMA approval. Authorities in the Austrian capital, Vienna, already have begun vaccinating the 5 to 11 age group. Europe is currently at the epicenter of the pandemic and the World Health Organisation has warned the continent could see deaths top 2 million by the spring unless urgent measures are taken.

Subscriber Only Stories
Tucked away in the heart of Kolkata’s Cossipore area lies the city’...Premium
How RBI has cut the growth forecast by raising itPremium
Shashi Tharoor: ‘I don’t think everyone who voted BJP in 2014...Premium
Ahead of Centre’s ban, chorus from Sangh, affiliatesPremium

The EMA green light for the vaccine developed by Pfizer and German company BioNTech has to be rubber-stamped by the EU’s executive branch, the European Commission, before health authorities in member states can begin administering shots.

Earlier this week, Germany’s health minister Jens Spahn said shipping of vaccines for younger children in the EU would begin on Dec. 20.

The United States signed off on Pfizer’s kids-sized shots earlier this month, followed by other countries including Canada.

Advertisement

Pfizer tested a dose that is a third of the amount given to adults for elementary school-age children. Even with the smaller shot, children who are 5 to 11 years old developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press in September.

But the studies done on Pfizer’s vaccine in children haven’t been big enough to detect any rare side effects from the second dose, like the chest and heart inflammation that has been seen in mostly male older teens and young adults.

American officials noted that COVID-19 has caused more deaths in children in the 5 to 11 age group than some other diseases, such as chickenpox, did before children were routinely vaccinated.

Advertisement

Earlier this month, the EMA said it began evaluating the use of Moderna Inc.s COVID-19 vaccine for children ages 6 to 11; it estimated that a decision would be made within two months.

Although children mostly only get mild symptoms of COVID-19, some public health experts believe immunising them should be a priority to reduce the virus’ continued spread, which could theoretically lead to the emergence of a dangerous new variant.

Researchers disagree on how much kids have influenced the course of the pandemic. Early research suggested they didn’t contribute much to viral spread. But some experts say children played a significant role this year spreading contagious variants such as alpha and delta.

In a statement this week, WHO said that because children and teens tend to have milder COVID-19 disease than adults, “it is less urgent to vaccinate them than older people, those with chronic health conditions and health workers.”

It has appealed to rich countries to stop immunising children and asked them to donate their doses immediately to poor countries who have yet to give a first vaccine dose to their health workers and vulnerable populations.

Advertisement

Still, WHO acknowledged that there are benefits to vaccinating children and adolescents that go beyond the immediate health benefits.

“Vaccination that decreases COVID transmission in this age group may reduce transmission from children and adolescents to older adults, and may help reduce the need for mitigation measures in schools,” WHO said.

First published on: 25-11-2021 at 06:31:54 pm
Next Story

The hubble telescope checks in with the most distant planets

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement